Renal Mechanism of SGLT2 Inhibition
Conditions: Type 2 Diabetes; Diabetic Kidney Disease Interventions: Drug: SGLT2 inhibitor Sponsors: University of Michigan; University of Colorado, Denver; Renal Pre-Competitive Consortium (RPC3) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Research | SGLT2 Inhibitors | Urology & Nephrology